The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Late-Onset Systemic Lupus Erythematosus: A Personal Series of 47 Patients and Pooled Analysis of 714 Cases in the Literature
Abstract
Systemic lupus erythematosus (SLE) is uncommon after the age of 50 years, and studies of elderly patients with SLE are scarce. We conducted the current study to analyze characteristics and outcome of patients with late-onset SLE in a French tertiary referral center, and to compare them with those of younger patients with SLE. From 1980 to 2000, 47 patients were identified as having late-onset SLE, defined as SLE diagnosed at or over the age of 50 years. These patients were compared with a group of 114 randomly selected patients aged younger than 50 years at SLE diagnosis. We compared clinical characteristics, laboratory data, therapy, and course. The female to male ratio was smaller in the late-onset SLE group (p = 0.0012). Some manifestations occurred less frequently in late-onset SLE: arthritis (p = 0.009), malar rash (p = 0.013), and nephropathy (p = 0.009). High-dose corticosteroids (p = 0.0016) and immunosuppressive drugs (p = 0.006) were less commonly used in the elderly. Deaths occurred more frequently in late-onset SLE (p = 0.019), with a 10-year survival rate of 71% versus 95% in early-onset SLE (p < 0.01). In patients with late-onset SLE, causes of death were usually unrelated to SLE. Analysis of pooled data from the literature, based on 714 old and 4700 young SLE patients, confirmed that late-onset SLE was characterized by a smaller female to male ratio (4.4:1 vs. 10.6:1; p = 3.10); a higher occurrence of serositis (36.7% vs. 28.6%; p = 7.10) and pulmonary involvement (21.2% vs. 11.3%; p = 6.10); and a lower occurrence of malar rash (31.1% vs. 62.4%; p = 10), photosensitivity (26.2% vs. 38.2%; p = 6.10), purpura/cutaneous vasculitis (13.4% vs. 25.9%; p = 9.10), alopecia/hair loss (24% vs. 44.9%; p = 3.10), Raynaud phenomenon (24.8% vs. 37.2%; p = 3.10), neuropsychiatric manifestations (15.3% vs. 20.2%; p = 0.025), lymphadenopathy (9.1% vs. 19.6%; p = 2.10), nephrotic syndrome (8.1% vs. 24.3%; p = 0.015), and nephritis (28.6% vs. 42.7%; p = 2.10). Regarding laboratory features, rheumatoid factor positivity was more frequent (32.7% vs. 20.1%; p = 3.10), whereas anti-RNP positivity (10.4% vs. 20.9%; p = 9.10), anti-Sm positivity (9.1% vs. 17.1%; p = 0.001), and a low CH50 complement fraction (45% vs. 64.9%; p = 0.002) were less frequent in old compared with young SLE patients. In conclusion, the clinical pattern of late-onset SLE is characterized by a lower disease severity. The reduced survival observed in this group seems to result mainly from the consequences of aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
SYSTEMIC LUPUS ERYTHEMATOSUS: REVIEW OF THE LITERATURE AND CLINICAL ANALYSIS OF 138 CASES
HARVEY, A. M., SHULMAN, L. E., TUMULTY, P. A., CONLEY, C. L., & SCHOENRICH, E. H. (1954) · Medicine · doi:10.1097/00005792-195412000-00001 · Cited by 993
CERVERA, R., KHAMASHTA, M. A., FONT, J., SEBASTIANI, G. D., GIL, A., LAVILLA, P., DOMÉNECH, I., AYDINTUG, A. O., JEDRYKA-GÓRAL, A., RAMÓN, E. D., et al. (1993) · Medicine · doi:10.1097/00005792-199303000-00005 · Cited by 979
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Clinical Manifestations of Systemic Lupus Erythematosus: Computer Analysis of 520 Cases
Dubois, E. L., & Tuffanelli, D. L. (1964) · JAMA · doi:10.1001/jama.1964.03070150014003 · Cited by 728
Ward, M. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199902)42:2<338::aid-anr17>3.0.co;2-u · Cited by 529
Primary Sjögren Syndrome: Clinical and Immunologic Disease Patterns in a Cohort of 400 Patients
GARCÍA-CARRASCO, M., RAMOS-CASALS, M., ROSAS, J., PALLARÉS, L., CALVO-ALEN, J., CERVERA, R., FONT, J., & INGELMO, M. (2002) · Medicine · doi:10.1097/00005792-200207000-00003 · Cited by 443
HOCHBERG, M. C., BOYD, R. E., AHEARN, J. M., ARNETT, F. C., BIAS, W. B., PROVOST, T. T., & STEVENS, M. B. (1985) · Medicine · doi:10.1097/00005792-198509000-00001 · Cited by 398
Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
Abu‐Shakra, M., Urowitz, M. B., Gladman, D. D., & Gough, J. (1995) · PubMed · Cited by 376
Cited by
Gender differences in autoimmune disease
Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Pons-Estel, G. J., Alarcón, G. S., Scofield, L., Reinlib, L., & Cooper, G. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.007 · Cited by 908
Differences in disease phenotype and severity in SLE across age groups
Ambrose, N., Morgan, T. A., Galloway, J., Ionnoau, Y., Beresford, M. W., & Isenberg, D. A. (2016) · Lupus · doi:10.1177/0961203316644333 · Cited by 274
Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan
Desai, M. K., & Brinton, R. D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00265 · Cited by 273
Zhang, H., Zhang, Y., Wang, Y.-F., Morris, D., Hirankarn, N., Sheng, Y., Shen, J., Pan, H.-F., Yang, J., Yang, S., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1590-3 · Cited by 25
Metadata
- Authors
- Boddaert, J., Huong, D. L. T., Amoura, Z., Wechsler, B., Godeau, P., & Piette, J.-C.
- Venue
- Medicine
- Published
- 2004-11
- Volume
- 83
- Issue
- 6
- Pages
- 348-359
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W1987054275
- Cited by
- 261
- References
- 45
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Late-Onset Systemic Lupus Erythematosus: A Personal Series of 47 Patients and Pooled Analysis of 714 Cases in the Literature. https://app.cochat.ai/papers/10.1097/01.md.0000147737.57861.7c
- The paper
- Boddaert, J., Huong, D. L. T., Amoura, Z., Wechsler, B., Godeau, P., & Piette, J.-C. (2004). Late-Onset Systemic Lupus Erythematosus: A Personal Series of 47 Patients and Pooled Analysis of 714 Cases in the Literature. Medicine. https://doi.org/10.1097/01.md.0000147737.57861.7c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.